Evaluation of the Efficacy and Safety of Suppressive Therapy With DALBAVANCINE in Device Infections

NCT06089044 · clinicaltrials.gov ↗

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Prosthesis-related Infections

Interventions

DRUG: Dalbavancin Injection

Sponsor

Tourcoing Hospital